Results 61 to 70 of about 17,469 (165)
Appraising the visibility, relevance and impacts of clinical pharmacology
British Journal of Clinical Pharmacology, Volume 91, Issue 7, Page 1884-1898, July 2025.Aims Clinical pharmacology (CP) used to be a strong medical and scientific field, but during the last three decades it seems to have lost some of its appeal. We reviewed the visibility, relevance and impact of CP and clinical pharmacologists across the globe and suggest ways to strengthen the discipline to address future pharmacotherapeutic challenges.
Serge Cremers +5 more
wiley +1 more source
Therapeutic Options for Visceral Leishmaniasis [PDF]
Drugs, 2013 Visceral leishmaniasis (VL), also known as Kala-Azar, is a disseminated protozoal infection caused principally by Leishmania donovani and Leishmania infantum (known as Leishmania chagasi in South America). The therapeutic options for VL are diverse and depend on different factors, such as the geographical area of the infection, development of ...
Begoña Monge-Maillo +1 more
openaire +3 more sources
BMC Research Notes, 2018 Objective Based on studies in India (as there was no studies from outside India) amphotericin B deoxycholate has been considered as a backup drug for treatment of visceral leishmaniasis.
Md Golam Hasnain +7 more
doaj +1 more source
A case of visceral leishmaniasis mimicking connective tissue disease
Rheumatology &Autoimmunity, EarlyView.
Yucui Li +4 more
wiley +1 more source
Small, Volume 21, Issue 29, July 24, 2025.This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai +5 more
wiley +1 more source
Interventions for visceral leishmaniasis
Cochrane Database of Systematic Reviews, 2010 Reason for withdrawal from publication This protocol is being withdrawn from The Cochrane Library. The authors have made no progress with this protocol in seven years. The protocol is out of date and does not meet the current methodological standards of Cochrane.
Urbà González +6 more
openaire +3 more sources
Public Health Challenges, Volume 4, Issue 2, June 2025.An update on the composition and distribution of sand fly species in the Nile environments of Khartoum. Variations were observed in species number than in species composition. The study will be a good reference for future studies on sandflies after the change in their habitat due to the current war in Sudan. ABSTRACT Phlebotomine sand flies are vectors
Suhaib A. Gumaa +3 more
wiley +1 more source
Visceral leishmaniasis in lung transplantation
Transplantation Proceedings, 2003 Infection by intracellular microorganisms with a special geographic distribution, such as Leishmania spp, has been reported in a limited number of patients undergoing solid-organ transplant (SOT). No cases of Leishmania spp infection in lung transplant patients were found in a review of the literature.
Morales, P. +5 more
openaire +3 more sources
Vulnerability to the transmission of human visceral leishmaniasis in a Brazilian urban area
Revista de Saúde PúblicaOBJECTIVE To analyze the determinants for the occurrence of human visceral leishmaniasis linked to the conditions of vulnerability. METHODS This is an ecological study, whose spatial analysis unit was the Territorial Analysis Unit in Araguaína, State ...
Celina Roma Sánchez de Toledo +5 more
doaj +1 more source